{"id":6472,"date":"2012-02-22T13:52:00","date_gmt":"2012-02-22T13:52:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/pharma-marketing-vs-insurance-marketing\/"},"modified":"2019-02-21T01:19:58","modified_gmt":"2019-02-21T01:19:58","slug":"pharma-marketing-vs-insurance-marketing","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/","title":{"rendered":"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico"},"content":{"rendered":"<p>Often, when proponents of pharma eMarketing get together at industry conferences, or cry into their beers at receptions afterward, they lament the fact that the drug industry isn&#8217;t doing as much as other industries in the &#8220;e&#8221; arena. Sometimes, they cite eMarketing campaigns of companies like Procter &amp; Gamble (P&amp;G) and ask, Why aren&#8217;t drug companies doing that?<\/p>\n<p>The responses to that question generally fall into the category of &#8220;It&#8217;s Regulations, Stupid!&#8221; That is, FDA regulations are hampering what pharma marketers can do online. The packaged goods industry &#8212; of which P&amp;G is a member &#8212; is not regulated like the drug industry is regulated. True that!<\/p>\n<p>So, let&#8217;s look at another industry that IS regulated: the insurance industry. Where do insurance marketers spend their dollars and how does that compare with pharma? It just so happens that I came across some data that might shed some light on that (see the chart below; click on the chart to enlarge).<\/p>\n<div class=\"separator\" style=\"clear: both; text-align: center;\">\n<a href=\"http:\/\/1.bp.blogspot.com\/-DRoom46e6MA\/T0Tmxi9m0UI\/AAAAAAAADsE\/hiLyCOi6_A4\/s1600\/MediaSpend_Pharma_v_Insur.jpg\" imageanchor=\"1\" style=\"margin-left: 1em; margin-right: 1em;\"><img loading=\"lazy\" decoding=\"async\" border=\"0\" height=\"180\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/02\/MediaSpend_Pharma_v_Insur.jpg\" width=\"400\" \/><\/a><\/div>\n<p>\nThe data come from Kantar Media. The Internet data does NOT include search advertising. The insurance data is for the first three quarters of 2011 (total spend = $3.56 Bn) whereas the data for pharma is for 2010&nbsp;&nbsp;(total spend = $4.3 Bn). To compare apples to apples, in 2010 the insurance industry media spend pie looks like this: TV, 54%; Print, 6%; Internet, 21%.<\/p>\n<p>No matter how you look at it, the insurance industry favors Internet over print whereas the opposite is true for pharma. Why?<\/p>\n<p>Here&#8217;s what I have learned from personal experience. In my family &#8212; and probably in your family too &#8212; health decisions and purchases are generally the domain of my wife, whereas insurance decisions and purchases are my responsibility. It&#8217;s no secret that pharma marketers target mostly women. My wife reads magazines like Prevention, etc. that feature a lot of drug ads. I don&#8217;t read these magazines. While I have seen print ads for insurance companies, they haven&#8217;t made much of an impression on me, whereas TV ads have.<\/p>\n<p>So, from my personal experience, it&#8217;s logical that both industries allocate a big portion of their media spend on TV advertising, but only the drug industry spends a lot on print advertising.<\/p>\n<p>What&#8217;s surprising, however, is the insurance industry&#8217;s 28% of total media spend on the Internet (versus 5% for the pharma industry).<\/p>\n<p>Coincidentally, yesterday I received an e-mail message from Geico about their &#8220;Family Pricing Program&#8221; for my son Greg. (We are Geico customers, having both our car and home insurance with them.) The message said:<\/p>\n<p>\n&#8220;If Gregory is getting ready to graduate, preparing for a new job, or looking to establish a little independence, our Family Pricing program allows you the freedom of moving Gregory to his own policy while he continues to receive the same great rates you&#8217;re currently receiving.&#8221;<\/p>\n<p>That spooked me a bit because Greg just started his first full-time job after graduating and I mentioned to my wife that soon it will be time for Greg to get his own insurance policy! I tweeted:<\/p>\n<p>\n&#8220;Got email from Geico about transferring my son 2 his own car insur plan now that he has a job. How&#8217;d they know I was just thinking that?&#8221;<\/p>\n<p>Of course, they didn&#8217;t know what I was thinking, but it was nice to know that they anticipated what I may be thinking! Geico knows a lot about me and my family. They know our ages, our sex, our driver&#8217;s license numbers, our driving records, what kinds of cars we own, etc. I had to give them that information to get insurance. No big deal.<\/p>\n<p>So, it would be easy for Geico to anticipate that Greg recently graduated and that he may have a new job. Further, they know from experience that parents want to get their kids off their insurance plans ASAP.<\/p>\n<p>After I posted that tweet, I received this response from &#8220;Shay&#8221; tweeting from the @GEICO_Service Twitter account:<\/p>\n<p>\n&#8220;We would be more than happy to give him a quote! He can go to geico.com or give us a call at 1-800-861-8380. -Shay&#8221;<\/p>\n<p>That was a pleasant note that makes this whole experience even more personal than if I just got an e-mail message.<\/p>\n<p>When I complained that Greg was likely to push back on the idea of paying his own insurance, Shay reassured me that &#8220;We will do everything we can!&#8221; and added: &#8220;Thank you so much for being part of the GEICO family!&#8221;<\/p>\n<p>I don&#8217;t think I can leverage this new found &#8220;family&#8221; relationship to get an even better deal from Geico, but the experience made me an even better fan of Geico &#8212; I was already impressed with their online services. Hopefully, if we ever need to make a claim, I will be equally impressed.<\/p>\n<p>Can the pharmaceutical industry do something similar? I&#8217;m not sure. The first hurdle for pharma is breaking away from print. As I said, pharma marketers may depend upon print to reach their core audience &#8212; women. But they may be ignoring social media&#8217;s ability to reach that core &#8212; listen, for example, to this podcast: &#8220;<a href=\"http:\/\/www.talk.pharma-mkting.com\/show152.htm\">How to Score With Women (as a Marketer) via Social Media<\/a>.&#8221;<\/p>\n<p>Keep in mind, however, that social media marketing is virtually &#8220;free&#8221; compared to print advertising, which is something the packaged goods industry is learning (see &#8220;<a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/news\/pmn112-article04.htm\">The Coming Pharma Digital Depression<\/a>&#8220;). Given that, even if pharma moves big time into social media marketing, I&#8217;m not sure the spend pie would look much different. The insurance industry probably spends a lot more on internet display advertising and e-mail direct marketing than does the pharma industry. These activities are much more expensive than paying Shay to reach out to me via Twitter!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Often, when proponents of pharma eMarketing get together at industry conferences, or cry into their beers at receptions afterward, they lament the fact that the drug industry isn&#8217;t doing as much as other industries in the &#8220;e&#8221; arena. Sometimes, they cite eMarketing campaigns of companies like Procter &amp; Gamble (P&amp;G) and ask, Why aren&#8217;t drug [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":10598,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[115,527,417,721,207],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Often, when proponents of pharma eMarketing get together at industry conferences, or cry into their beers at receptions afterward, they lament the fact that the drug industry isn&#8217;t doing as much as other industries in the &#8220;e&#8221; arena. Sometimes, they cite eMarketing campaigns of companies like Procter &amp; Gamble (P&amp;G) and ask, Why aren&#8217;t drug [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2012-02-22T13:52:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:19:58+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/02\/MediaSpend_Pharma_v_Insur.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"182\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/\",\"name\":\"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2012-02-22T13:52:00+00:00\",\"dateModified\":\"2019-02-21T01:19:58+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico - Pharma Marketing Network","og_description":"Often, when proponents of pharma eMarketing get together at industry conferences, or cry into their beers at receptions afterward, they lament the fact that the drug industry isn&#8217;t doing as much as other industries in the &#8220;e&#8221; arena. Sometimes, they cite eMarketing campaigns of companies like Procter &amp; Gamble (P&amp;G) and ask, Why aren&#8217;t drug [&hellip;]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/","og_site_name":"Pharma Marketing Network","article_published_time":"2012-02-22T13:52:00+00:00","article_modified_time":"2019-02-21T01:19:58+00:00","og_image":[{"width":400,"height":182,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2012\/02\/MediaSpend_Pharma_v_Insur.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/","name":"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2012-02-22T13:52:00+00:00","dateModified":"2019-02-21T01:19:58+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/pharma-marketing-vs-insurance-marketing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"Pharma Marketing Vs. Insurance Marketing: What Pharma Can Learn from Geico"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6472"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=6472"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6472\/revisions"}],"predecessor-version":[{"id":10599,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6472\/revisions\/10599"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/10598"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=6472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=6472"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=6472"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=6472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}